Therefore, although pancreatic cancer has yet to show response to anti-PD-1/PD-L1 therapy, it would still be beneficial to understand the mechanism underlying the regulation of PD-L1 expression. The gene discussed is PDCD1; the disease is familial pancreatic carcinoma.